Items without sitelinks
From determinar.ia.br - Determine suas informações
Showing below up to 50 results in range #21,251 to #21,300.
- Renal mass (Q91559)
- Ureter filling defect (Q91558)
- Fibroepithelial neoplasms- ICD-O3 view (Q91557)
- Malignant neoplasms of respiratory or intrathoracic organs (Q91556)
- Bladder filling defect (Q91555)
- Kidney filling defect (Q91554)
- Parkinsonism in hereditary spastic paraplegia (Q91553)
- Gynandroblastoma of ovary (Q91552)
- Parkinsonism due to spinocerebellar ataxias (Q91551)
- Screening for intestinal protozoal disease (Q91550)
- Parkinsonism in Wilson's disease (Q91549)
- Ovarian malignant Sertoli-Leydig cell tumour (Q91548)
- Vitiligo of upper eyelid or periocular area (Q91547)
- Exposure to excessive cold of human origin, undetermined intent (Q91546)
- Cutaneous microvascular occlusion by emboli (Q91545)
- Cutaneous microvascular disturbances due to dysproteinaemia (Q91544)
- Parkinsonism due to Neurodegeneration with brain iron accumulation NBIA (Q91543)
- Cutaneous microvascular disturbances due to vascular coagulopathies (Q91542)
- Exposure to excessive cold of natural origin, undetermined intent (Q91541)
- Glomerular disorders in plasmodium malariae malaria (Q91540)
- Drug-induced osteonecrosis, humerus (Q91539)
- Parkinsonism in Huntington disease (Q91538)
- X-linked dystonia parkinsonism (Q91537)
- Vitiligo of lower eyelid or periocular area (Q91536)
- Cutaneous microvascular occlusion by platelet plugs (Q91535)
- Theca steroid-producing cell malignant tumour, not further specified (Q91534)
- Cutaneous microvascular occlusion due to systemic coagulopathies (Q91533)
- Certain specified motility disorder (Q91532)
- Intentional self-harm by exposure to or harmful effects of other nonsteroidal anti-inflammatory drugs (Q91531)
- Intentional self-harm by exposure to or harmful effects of paracetamol (Q91530)
- Adult Krabbe disease (Q91529)
- Moyamoya disease (Q91528)
- Infantile Krabbe disease (Q91527)
- Secondary moyamoya (Q91526)
- Late-infantile or juvenile Krabbe disease (Q91525)
- Intentional self-harm by exposure to or harmful effects of 4-Aminophenol derivatives (Q91524)
- Cholera screening (Q91523)
- Intentional self-harm by exposure to or harmful effects of ibuprofen (Q91522)
- Intentional self-harm by exposure to or harmful effects of indomethacin (Q91521)
- Screening for intestinal helminthiasis (Q91520)
- Intentional self-harm by exposure to or harmful effects of other propionic acid derivatives (Q91519)
- Intentional self-harm by exposure to or harmful effects of aspirin (Q91518)
- Intentional self-harm by exposure to or harmful effects of other salicylates (Q91517)
- Unintentionally struck, kicked, or bumped by land mammal (Q91516)
- Intentional self-harm by exposure to or harmful effects of antirheumatics, not elsewhere classified (Q91515)
- Intentional self-harm by exposure to or harmful effects of pyrazolone derivatives (Q91514)
- Hydrocephalus due to congenital toxoplasmosis (Q91513)
- Entanglement of cords of twins in monoamniotic sac (Q91512)
- Congenital toxoplasma encephalitis (Q91511)
- General or plastic surgery devices associated with adverse incidents, liposuction equipment (Q91510)
